glp-1 liver toxicity Revolutionizing MASLD treatment with receptor agonists The Role of GLP1-RAs in
Description
Is your metabolism functioning optimally
Curr Opin Genet Dev
This dual action improves glycaemic control without significantly increasing hypoglycaemia risk
GLP-1 receptor agonists like semaglutide and tirzepatide have become central to modern weight management, yet insurance approval remains inconsistent and often restricted to diabetes diagnoses
STEP 1 Trial, NEJM 2021 In people with type 2 diabetes or prediabetes, semaglutide stimulates insulin secretion in a glucose-dependent manner meaning it only acts when blood sugar is elevated
N Engl J Med 391(17):15731583
